These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8795592)

  • 61. Multiple sclerosis.
    Noseworthy JH; Lucchinetti C; Rodriguez M; Weinshenker BG
    N Engl J Med; 2000 Sep; 343(13):938-52. PubMed ID: 11006371
    [No Abstract]   [Full Text] [Related]  

  • 62. Updates in multiple sclerosis and related disorders: highlights of the 57th Annual Meeting of the American Academy of Neurology, April 9-16, 2005, Miami Beach, FL.
    Cook SD
    Rev Neurol Dis; 2005; 2(3):138-43. PubMed ID: 16400314
    [No Abstract]   [Full Text] [Related]  

  • 63. New acute and chronic black holes in patients with multiple sclerosis randomised to interferon beta-1b or glatiramer acetate.
    Cadavid D; Cheriyan J; Skurnick J; Lincoln JA; Wolansky LJ; Cook SD
    J Neurol Neurosurg Psychiatry; 2009 Dec; 80(12):1337-43. PubMed ID: 19687024
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Changes in quality of life in patients with remitted multiple sclerosis during the specific treatment with disease-modifying drugs: a comparative study of populations of Moscow and Novosibirsk].
    Popova EV; Riabukhina OV; Vorob'eva OV; Malkova NA; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(5 Pt 1):67-70. PubMed ID: 21322129
    [No Abstract]   [Full Text] [Related]  

  • 65. The uninvited guest. An overview of multiple sclerosis.
    Andes RJ
    Adv Nurse Pract; 2008 Jan; 16(1):37-40; quiz 41. PubMed ID: 20014741
    [No Abstract]   [Full Text] [Related]  

  • 66. Workshop on primary progressive multiple sclerosis: meeting summary.
    Montalban X; Thompson AJ
    Mult Scler; 2002 Apr; 8(2):177-8. PubMed ID: 11990876
    [No Abstract]   [Full Text] [Related]  

  • 67. Diagnosis and disease modifying treatments in multiple sclerosis.
    Zajicek J
    Postgrad Med J; 2005 Sep; 81(959):556-61. PubMed ID: 16143683
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Interferon beta treatment for multiple sclerosis.
    Galazka A
    Lancet; 1999 Feb; 353(9151):495; author reply 497-8. PubMed ID: 9989740
    [No Abstract]   [Full Text] [Related]  

  • 69. [Pathogenesis and treatment of multiple sclerosis (state of the art in 2000)].
    Zavalishin IA; Zhuchenko TD; Peresedova AV
    Vestn Ross Akad Med Nauk; 2001; (7):18-22. PubMed ID: 11523422
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Immunomodulatory therapy in multiple sclerosis].
    Csépány T; Bereczki D
    Ideggyogy Sz; 2004 Nov; 57(11-12):401-16. PubMed ID: 15662768
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Glatiramer acetate: a review of its use in relapsing-remitting multiple sclerosis.
    Simpson D; Noble S; Perry C
    CNS Drugs; 2002; 16(12):825-50. PubMed ID: 12421116
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The effect of immunomodulatory treatment on multiple sclerosis fatigue.
    Metz LM; Patten SB; Archibald CJ; Bakker JI; Harris CJ; Patry DG; Bell RB; Yeung M; Murphy WF; Stoian CA; Billesberger K; Tillotson L; Peters S; McGowan D
    J Neurol Neurosurg Psychiatry; 2004 Jul; 75(7):1045-7. PubMed ID: 15201369
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A practical guide to pediatric multiple sclerosis.
    Huppke P; Gärtner J
    Neuropediatrics; 2010 Aug; 41(4):157-62. PubMed ID: 21086219
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Treatment effects of immunomodulatory therapies at different stages of multiple sclerosis in short-term trials.
    Bates D
    Neurology; 2011 Jan; 76(1 Suppl 1):S14-25. PubMed ID: 21205678
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [A possible effect of the immunomodulating therapy with beta-interferons and glatimer acetate on the development of thyroid disease in patients with multiple sclerosis].
    Petrova LV; Boĭkova AN; Batysheva TT; Gusev EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(2 Pt 2):58-67. PubMed ID: 21916158
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Drug treatment of multiple sclerosis.
    Polman CH; Uitdehaag BM
    BMJ; 2000 Aug 19-26; 321(7259):490-4. PubMed ID: 10948033
    [No Abstract]   [Full Text] [Related]  

  • 77. Interferon beta in multiple sclerosis.
    Arnason BG
    Neurology; 1993 Apr; 43(4):641-3. PubMed ID: 8469315
    [No Abstract]   [Full Text] [Related]  

  • 78. Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis.
    Paty DW; Li DK; Oger JJ; Kastrukoff L; Koopmans R; Tanton E; Zhao GJ
    Ann Neurol; 1994; 36 Suppl():S95-6. PubMed ID: 8017896
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Interferon beta-1b.
    Goodkin DE
    Lancet; 1994 Dec; 344(8938):1702-3. PubMed ID: 7996978
    [No Abstract]   [Full Text] [Related]  

  • 80. Interferon beta in the management of multiple sclerosis.
    Pender MP
    Aust N Z J Med; 1996 Jun; 26(3):343. PubMed ID: 8811205
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.